lapatinib

Pronunciation:(luh-PA-tih-nib)

Definition: A drug used to treat HER2 positive (HER2+) breast cancer that is advanced or has spread to other parts of the body. It is used with capecitabine in patients whose cancer has not gotten better with other anticancer drugs. It is used with letrozole in postmenopausal women whose cancer is hormone receptor positive (HR+) and who need hormone therapy. It is also being studied in the treatment of other types of cancer. Lapatinib blocks epidermal growth factor receptor (EGFR) and other proteins, which may help keep cancer cells from growing. Lapatinib is a type of ErbB2 and EGFR dual tyrosine kinase inhibitor. Also called GW572016, lapatinib ditosylate, and Tykerb.Cancer.govPatient

lapatinibMedicamento que se usa junto con otro medicamento anticanceroso para tratar el cáncer de mama que es positivo al HER2 y que ha avanzado o se ha metastatizado (diseminado hasta otras partes del cuerpo) después de haber sido tratado con otros medicamentos. Lapatinib también está en estudio para el tratamiento de otros tipos de cáncer. Es un tipo de inhibidor dual de la tirosina cinasa de ErbB-2 y RFCE. También se llama ditosilato de lapatinib, GW572016, y Tykerb.Cancer.govPatient2004-11-22 Date last modified: 2018-06-07Lapatinib Ditosylate